GlassScriptPhysician profile
Jason Poston
NPI 1457527772
$10,601.59
in general payments reported to CMS, 2019-2025
22 companies · $452 in 2025
The $452 reported for 2025 was less than what a typical Pain Medicine (Anesthesiology) provider received nationally (typical 2025 total: $458).
See the full distribution for Pain Medicine (Anesthesiology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,003 · 2020: $928 · 2021: $1,319 · 2022: $3,677 · 2023: $654 · 2024: $568 · 2025: $452.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,674.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,674.35 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Relievant Medsystems, INC. | $2,913.89 | 2022-2023 | Intracept |
| Boston Scientific Corporation | $2,109.28 | 2019-2025 | Wavewriter Alpha Prime 16, General - Pain Management, Intracept |
| Flowonix Medical Incorporated | $1,464.58 | 2019 | |
| Abbott Laboratories | $1,291.20 | 2019-2024 | Proclaim, Eterna |
| Surgentec | $756.75 | 2021 | |
| Medtronic, INC. | $477.35 | 2022-2025 | Intellis Adaptivestim, Synchromedii, Inceptiv |
| Nalu Medical, INC. | $469.92 | 2020-2025 | Nalu Neurostimulation System |
| Medtronic USA, INC. | $236.96 | 2019-2020 | |
| Abbvie INC. | $236.57 | 2022-2025 | |
| Stimwave Technologies Incorporated | $180.43 | 2019 | |
| Nevro Corp. | $135.72 | 2019-2022 | |
| Teva Pharmaceuticals USA, INC. | $74.76 | 2019-2025 | Ajovy, Austedo Xr |
| Vertex Pharmaceuticals Incorporated | $68.45 | 2024-2025 | |
| Saluda Medical Americas, INC. | $34.70 | 2024 | Evoke |
| Allergan, INC. | $29.67 | 2020-2022 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tersera Therapeutics LLC | $25.62 | 2019 | |
| Pfizer INC. | $23.81 | 2019 | |
| Radius Health, INC. | $21.54 | 2020 | |
| Scilex Pharmaceuticals INC. | $14.93 | 2020 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $12.68 | 2019 | |
| Vertos Medical, INC. | $11.83 | 2024 | Mild Device Kit |
| Spr Therapeutics, INC | $10.95 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jason Poston listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.